- BrainCheck is a digital health platform specializing in neurocognitive assessment and care management, primarily targeting the concussion and dementia markets with its mobile and browser-accessible cognitive health tools.
- In February 2026, BrainCheck raised $13 million in Series A3 funding, bringing its total funding to approximately $58.15 million, and appointed Dr. Stephen Bekanich as Chief Medical Officer to enhance its clinical strategy.
- The company has expanded its user base significantly, with 150 new practices adopting its cognitive care workflows in 2025, and it integrates its tools with electronic health records to streamline cognitive care delivery.
- Ideal buyers include healthcare providers and organizations focused on cognitive health, as BrainCheck addresses the growing need for efficient cognitive assessments and care planning solutions in a rapidly aging population.
BrainCheck's workforce is organized into nine distinct departments, with the largest being Executive (6 employees), Engineering (5 employees), and Sales (5 employees). This balanced departmental mix reflects a strong focus on leadership, technical development, and revenue generation. Other departments, such as Operations and Information Technology, further support the company's core functions, while Community and Social Services and Marketing contribute to its outreach and engagement efforts.
The company's workforce is distributed across seven locations, with the highest concentration in Houston, TX (6 employees) and Austin, TX (5 employees). This geographic distribution indicates a significant presence in Texas, while other locations, including Edison, NJ, and Syracuse, NY, contribute to a more diverse operational footprint. The 'Other' category, encompassing 19 employees, suggests a remote or distributed work model, enhancing flexibility and talent acquisition across various regions.
